Market overview
The global carpal tunnel release system market is worth USD 127 mn in 2026 and is forecast to reach USD 217 mn by 2036, growing at a 5.5% CAGR. United States is the largest country market and Endoscopic release systems is the largest by technique segment.
| Scope | Single-use and reusable devices for minimally invasive release of the transverse carpal ligament: endoscopic systems, ultrasound-guided knives and mini-incision instrument sets. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 120 mn |
| Value 2026 | USD 127 mn |
| Value 2036 | USD 217 mn |
| CAGR 2026-2036 | 5.5% |
| Volume 2026 | 348 thousand procedure kits |
| Volume 2036 | 566 thousand procedure kits |
| Average price 2026 | USD 366 per procedure kit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Carpal Tunnel Release System market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 127 mn |
| 2027 | USD 134 mn |
| 2028 | USD 142 mn |
| 2029 | USD 149 mn |
| 2030 | USD 158 mn |
| 2031 | USD 166 mn |
| 2032 | USD 175 mn |
| 2033 | USD 185 mn |
| 2034 | USD 195 mn |
| 2035 | USD 206 mn |
| 2036 | USD 217 mn |
Carpal Tunnel Release System market segmentation
By technique
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Endoscopic release systems | 48.0% | 43.0% | USD 61 mn | 4.3% |
| Ultrasound-guided systems | 24.0% | 34.2% | USD 31 mn | 9.3% |
| Mini-open instrument sets | 28.0% | 22.8% | USD 36 mn | 3.4% |
By setting
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Ambulatory surgery centres | 52.0% | 51.3% | USD 66 mn | 5.3% |
| Hospital outpatient | 34.0% | 30.5% | USD 43 mn | 4.4% |
| Office-based procedures | 14.0% | 18.2% | USD 18 mn | 8.3% |
By visualization
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Ultrasound guided | 20.0% | 26.0% | USD 25 mn | 8.3% |
| Endoscopic | 42.0% | 40.0% | USD 53 mn | 5.0% |
| Open instruments | 38.0% | 34.0% | USD 48 mn | 4.3% |
By approach
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Single portal | 34.0% | 34.0% | USD 43 mn | 5.5% |
| Dual portal | 30.0% | 29.0% | USD 38 mn | 5.1% |
| Open release | 36.0% | 37.0% | USD 46 mn | 5.8% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 44.0% | 40.0% | USD 56 mn | 4.5% |
| Ambulatory surgery centers | 40.0% | 43.0% | USD 51 mn | 6.3% |
| Specialty hand clinics | 16.0% | 17.0% | USD 20 mn | 6.1% |
Top 25 countries for carpal tunnel release system by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 96.0% of 2026 revenue and the 25 countries below together hold 98.8%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 79 mn | 62.0% | USD 133 mn | 5.4% |
| 2 | Germany | USD 7.6 mn | 6.0% | USD 13 mn | 5.3% |
| 3 | United Kingdom | USD 6.4 mn | 5.0% | USD 11 mn | 5.3% |
| 4 | Japan | USD 6.4 mn | 5.0% | USD 10 mn | 4.8% |
| 5 | France | USD 5.1 mn | 4.0% | USD 8.7 mn | 5.5% |
| 6 | Canada | USD 4.5 mn | 3.5% | USD 7.6 mn | 5.5% |
| 7 | Italy | USD 3.8 mn | 3.0% | USD 6.5 mn | 5.5% |
| 8 | China | USD 3.8 mn | 3.0% | USD 8.9 mn | 8.8% |
| 9 | Australia | USD 3.2 mn | 2.5% | USD 5.7 mn | 5.9% |
| 10 | Spain | USD 2.5 mn | 2.0% | USD 4.3 mn | 5.5% |
| 11 | Brazil | USD 0.55 mn | 0.4% | USD 1.00 mn | 6.2% |
| 12 | South Korea | USD 0.43 mn | 0.3% | USD 0.78 mn | 6.1% |
| 13 | Netherlands | USD 0.37 mn | 0.3% | USD 0.61 mn | 5.1% |
| 14 | Switzerland | USD 0.32 mn | 0.2% | USD 0.52 mn | 5.1% |
| 15 | Belgium | USD 0.28 mn | 0.2% | USD 0.46 mn | 5.0% |
| 16 | Sweden | USD 0.28 mn | 0.2% | USD 0.46 mn | 5.0% |
| 17 | Austria | USD 0.22 mn | 0.2% | USD 0.37 mn | 5.5% |
| 18 | Denmark | USD 0.20 mn | 0.2% | USD 0.35 mn | 5.5% |
| 19 | Mexico | USD 0.19 mn | 0.1% | USD 0.35 mn | 6.2% |
| 20 | Taiwan | USD 0.17 mn | 0.1% | USD 0.30 mn | 6.3% |
| 21 | Russia | USD 0.14 mn | 0.1% | USD 0.26 mn | 6.4% |
| 22 | Israel | USD 0.13 mn | 0.1% | USD 0.20 mn | 4.4% |
| 23 | Norway | USD 0.10 mn | 0.08% | USD 0.17 mn | 5.5% |
| 24 | Poland | USD 76 thousand | 0.06% | USD 0.15 mn | 7.1% |
| 25 | India | USD 76 thousand | 0.06% | USD 0.13 mn | 5.5% |
| Rest of world | USD 1.6 mn | 1.2% | USD 2.4 mn | 4.2% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Integra LifeSciences
- Smith and Nephew
- Arthrex
- Stryker
Group 2: Regional and specialist players
- Sonex Health
- Zimmer Biomet
Group 3: Emerging and niche players
- MicroAire
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the carpal tunnel release system market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 5.5% is calculated from the resulting values.
The market is divided by technique, by setting, by visualization, by approach, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the carpal tunnel release system market?
The global carpal tunnel release system market is estimated at USD 120 mn in 2025 and USD 127 mn in 2026.
How fast will the carpal tunnel release system market grow?
It is forecast to reach USD 217 mn by 2036, a compound annual growth rate of 5.5% from 2026, an increase of USD 90 mn.
Which country is the largest market for carpal tunnel release system?
United States is the largest market by revenue at USD 79 mn in 2026, 62.0% of the global total. The three largest countries together hold 73.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 8.8% a year from 2026 to 2036.
Which carpal tunnel release system segment is largest?
In the by technique split, Endoscopic release systems is the largest segment with 48.0% of 2026 revenue.
Who are the leading carpal tunnel release system companies?
Global leaders include Integra LifeSciences, Smith and Nephew, Arthrex, Stryker.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Intracameral AntibioticsUSD 128 mn · 6.5% CAGR
- Autonomous AI Powered Ophthalmology ScreeningUSD 124 mn · 16.0% CAGR
- Fiber Modular NutritionUSD 121 mn · 5.5% CAGR
- Impedance-based TEER Measurement SystemUSD 120 mn · 9.0% CAGR
- Medical Telepresence RobotsUSD 119 mn · 8.0% CAGR
- Otoacoustic Emissions Hearing ScreenerUSD 136 mn · 4.8% CAGR
- Cystic Fibrosis Nutrition ProductsUSD 145 mn · 3.5% CAGR
- Isokinetic Diagnostic and Training SystemUSD 110 mn · 5.5% CAGR